Silicon Valley Capital Partners Reduces Stock Holdings in UnitedHealth Group Incorporated $UNH

Key Points

• Silicon Valley Capital Partners reduced its holdings in UnitedHealth Group by 75.8%, now owning only 3,521 shares after selling 11,026 shares in the first quarter.
• UnitedHealth Group reported a net revenue of $111.62 billion, missing analyst expectations, along with a quarterly earnings per share of $4.08, falling short of the $4.45 consensus estimate.
• The company announced a quarterly dividend of $2.21 per share, reflecting an annualized rate of $8.84 and a yield of 2.5%.

Silicon Valley Capital Partners lessened its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 75.8% in the first quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 3,521 shares of the healthcare conglomerate's stock after selling 11,026 shares during the quarter. Silicon Valley Capital Partners' holdings in UnitedHealth Group were worth $1,817,000 as of its most recent filing with the Securities & Exchange Commission.

Other hedge funds and other institutional investors also recently made changes to their positions in the company. Bayforest Capital Ltd raised its holdings in shares of UnitedHealth Group by 685.7% during the first quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares in the last quarter. Clal Insurance Enterprises Holdings Ltd grew its stake in shares of UnitedHealth Group by 416.7% in the first quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock worth $32,000 after acquiring an additional 50 shares during the last quarter. IAG Wealth Partners LLC purchased a new stake in shares of UnitedHealth Group during the first quarter valued at $42,000. Copia Wealth Management purchased a new stake in shares of UnitedHealth Group during the fourth quarter valued at $42,000. Finally, O Brien Wealth Partners LLC boosted its position in shares of UnitedHealth Group by 74.0% during the first quarter. O Brien Wealth Partners LLC now owns 87 shares of the healthcare conglomerate's stock valued at $46,000 after buying an additional 37 shares during the last quarter. Institutional investors own 87.86% of the company's stock.

Wall Street Analyst Weigh In

Several research firms recently commented on UNH. HSBC reaffirmed a "reduce" rating and set a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research report on Wednesday, May 21st. Truist Financial raised their target price on UnitedHealth Group from $310.00 to $365.00 and gave the stock a "buy" rating in a research report on Tuesday. Wall Street Zen cut UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Saturday, May 24th. Oppenheimer dropped their target price on UnitedHealth Group from $400.00 to $325.00 and set an "outperform" rating on the stock in a research report on Wednesday, July 30th. Finally, Bank of America raised their target price on UnitedHealth Group from $290.00 to $325.00 and gave the stock a "neutral" rating in a research report on Monday, August 18th. Sixteen investment analysts have rated the stock with a Buy rating, six have issued a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, UnitedHealth Group currently has a consensus rating of "Moderate Buy" and a consensus price target of $358.95.

UnitedHealth Group Stock Performance

Shares of NYSE UNH traded down $1.00 during trading on Friday, hitting $352.61. The company had a trading volume of 13,985,550 shares, compared to its average volume of 18,883,918. The stock has a 50 day simple moving average of $291.98 and a 200 day simple moving average of $369.67. The firm has a market capitalization of $319.35 billion, a P/E ratio of 15.28, a price-to-earnings-growth ratio of 2.31 and a beta of 0.45. UnitedHealth Group Incorporated has a 12 month low of $234.60 and a 12 month high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85.

UnitedHealth Group (NYSE:UNH - Get Free Report) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). The business had revenue of $111.62 billion for the quarter, compared to the consensus estimate of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's revenue for the quarter was up 12.9% compared to the same quarter last year. During the same period last year, the business posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, analysts anticipate that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be issued a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.5%. The ex-dividend date is Monday, September 15th. UnitedHealth Group's dividend payout ratio (DPR) is currently 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.